ClinPlus Weekly Wrap

1. RBM: ‘Risks are not issues,’ Boehringer Ingelheim CROs have been experiencing increased pressure to implement risk-based monitoring (RBM), and while adoption has been slow, it is gaining speed, say speakers at CROWN Congress. 2. Trial Transparency: PR Hype or Added Value? Trial transparency is always a concern in the industry.  This article starts at the […]

ClinPlus Weekly Wrap

  1. India has ‘natural potential to grow’ in CRO space, says Syngene CEO India‚Äôs CRO industry is playing catch-up to the generic and manufacturing sectors, according to the departing CEO of one of the largest players, Syngene.   2. Type 2 Diabetes May Be Prevented If Weight Loss Happens Before Middle Age 30-year study […]

ClinPlus Weekly Wrap

  We are finishing up this week with discussions about the CTMS market, IT challenges for clinical trials and lack of cancer patients in trials. 1. CTMS market set to hit $2bn by 2019 yet CROs may not be the driver The global clinical trial management system (CTMS) market is expected to grow 14% over a […]